Hamilton Andrea, Robinson Carl, Sutcliffe Iain C, Slater Josh, Maskell Duncan J, Davis-Poynter Nick, Smith Ken, Waller Andrew, Harrington Dean J
University of Sunderland, Tyne and Wear SR1 3SD, United Kingdom.
Infect Immun. 2006 Dec;74(12):6907-19. doi: 10.1128/IAI.01116-06. Epub 2006 Oct 2.
Streptococcus equi is the causative agent of strangles, a prevalent and highly contagious disease of horses. Despite the animal suffering and economic burden associated with strangles, little is known about the molecular basis of S. equi virulence. Here we have investigated the contributions of a specific lipoprotein and the general lipoprotein processing pathway to the abilities of S. equi to colonize equine epithelial tissues in vitro and to cause disease in both a mouse model and the natural host in vivo. Colonization of air interface organ cultures after they were inoculated with a mutant strain deficient in the maturase lipoprotein (DeltaprtM(138-213), with a deletion of nucleotides 138 to 213) was significantly less than that for cultures infected with wild-type S. equi strain 4047 or a mutant strain that was unable to lipidate preprolipoproteins (Deltalgt(190-685)). Moreover, mucus production was significantly greater in both wild-type-infected and Deltalgt(190-685)-infected organ cultures. Both mutants were significantly attenuated compared with the wild-type strain in a mouse model of strangles, although 2 of 30 mice infected with the Deltalgt(190-685) mutant did still exhibit signs of disease. In contrast, only the DeltaprtM(138-213) mutant was significantly attenuated in a pony infection study, with 0 of 5 infected ponies exhibiting pathological signs of strangles compared with 4 of 4 infected with the wild-type and 3 of 5 infected with the Deltalgt(190-685) mutant. We believe that this is the first study to evaluate the contribution of lipoproteins to the virulence of a gram-positive pathogen in its natural host. These data suggest that the PrtM lipoprotein is a potential vaccine candidate, and further investigation of its activity and its substrate(s) are warranted.
马链球菌是马腺疫的病原体,马腺疫是一种在马中普遍且具有高度传染性的疾病。尽管这种疾病给动物带来痛苦并造成经济负担,但关于马链球菌毒力的分子基础却知之甚少。在此,我们研究了一种特定脂蛋白以及一般脂蛋白加工途径对马链球菌在体外定殖于马上皮组织以及在小鼠模型和天然宿主体内引发疾病能力的贡献。在用成熟酶脂蛋白缺陷型突变株(DeltaprtM(138 - 213),缺失核苷酸138至213)接种后,空气界面器官培养物的定殖明显少于用野生型马链球菌菌株4047或无法将前原脂蛋白脂化的突变株(Deltalgt(190 - 685))感染的培养物。此外,在野生型感染和Deltalgt(190 - 685)感染的器官培养物中,黏液产生均显著增加。在马腺疫小鼠模型中,与野生型菌株相比,这两种突变株均显著减毒,尽管感染Deltalgt(190 - 685)突变株的30只小鼠中有2只仍表现出疾病症状。相比之下,在一项小马感染研究中,只有DeltaprtM(138 - 213)突变株显著减毒,感染的5匹小马中0匹表现出马腺疫的病理症状,而感染野生型的4匹中有4匹出现症状,感染Deltalgt(190 - 685)突变株的5匹中有3匹出现症状。我们认为这是第一项评估脂蛋白对革兰氏阳性病原体在其天然宿主中毒力贡献的研究。这些数据表明,PrtM脂蛋白是一种潜在的疫苗候选物,有必要对其活性及其底物进行进一步研究。